Increased plasma levels of B-type natriuretic peptide in patients with unstable angina.

[1]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[2]  K. Kugiyama,et al.  Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. , 1988, Circulation.

[3]  J. Mehta,et al.  Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. , 1990, Journal of the American College of Cardiology.

[4]  K. Nakao,et al.  Increased Plasma Levels of Brain Natriuretic Peptide in Patients With Acute Myocardial Infarction , 1993, Circulation.

[5]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[6]  N. Minamino,et al.  Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. , 1989, Biochemical and biophysical research communications.

[7]  H. Itoh,et al.  Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. , 1995, Circulation.

[8]  P. Erne,et al.  Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. , 1986, The New England journal of medicine.

[9]  T. Benraad,et al.  Atrial natriuretic peptide after myocardial infarction. , 1989, American heart journal.

[10]  G. Reeder,et al.  Atrial natriuretic peptide elevation in congestive heart failure in the human. , 1986, Science.

[11]  K. Kugiyama,et al.  Simultaneous multivessel coronary artery spasm demonstrated by quantitative analysis of thallium-201 single photon emission computed tomography. , 1987, The American journal of cardiology.

[12]  K. Kugiyama,et al.  Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.

[13]  K. Nakao,et al.  Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious rats , 1988, Neuroscience Letters.

[14]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[15]  E. Braunwald,et al.  Unstable angina. A classification. , 1989, Circulation.

[16]  B. Puschendorf,et al.  EARLY DECREASE IN ATRIAL NATRIURETIC PEPTIDE IN ACUTE MYOCARDIAL INFARCTION , 1987, The Lancet.

[17]  M. Nobuyoshi,et al.  Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. , 1985, Circulation.

[18]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[19]  K. Nakao,et al.  Inhibitory effect of brain natriuretic peptide on central angiotensin II-stimulated pressor response in conscious rats , 1988, Neuroscience Letters.

[20]  K. Kugiyama,et al.  Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. , 1986, Circulation.

[21]  P. Needleman,et al.  Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. , 1986, The New England journal of medicine.

[22]  K. Hosoda,et al.  Augmented secretion of brain natriuretic peptide in acute myocardial infarction. , 1991, Biochemical and biophysical research communications.

[23]  H. Imura,et al.  Antidipsogenic action of a novel peptide, 'brain natriuretic peptide', in rats. , 1988, European journal of pharmacology.

[24]  J. Eidt,et al.  Specific Platelet Mediators and Unstable Coronary Artery Lesions: Experimental Evidence and Potential Clinical Implications , 1989, Circulation.

[25]  K. Nakao,et al.  Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. , 1995, The Journal of clinical investigation.

[26]  L. Wold,et al.  Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. , 1988, The Journal of clinical investigation.

[27]  G. Specchia,et al.  Increased Expression of Neutrophil and Monocyte Adhesion Molecules in Unstable Coronary Artery Disease , 1993, Circulation.

[28]  Michihisa Jougasaki,et al.  Different Secretion Patterns of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Patients With Congestive Heart Failure , 1993, Circulation.

[29]  W. Weintraub,et al.  Elevation of C-reactive protein in "active" coronary artery disease. , 1990, The American journal of cardiology.

[30]  J. Laragh,et al.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. , 1985, The New England journal of medicine.

[31]  J. Willerson,et al.  Role of inflammation in coronary plaque disruption. , 1994, Circulation.

[32]  A. D. de Bold,et al.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.

[33]  K. Inouye,et al.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. , 1991, The Journal of clinical investigation.